ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
121.448,06
1,19%
S&P 500
5.927,67
-0,80%
US Dollar vs BRL
6,0764
-0,66%
Bitcoin
97.224,75
-4,95%
Brent Oil
76,865
0,99%
As Melhores Corretoras Online
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Protagenic Therapeutics Inc (PTIX)

  7. Protagenic Therapeutics Inc (PTIX) Notícias

PTIX

Protagenic Therapeutics (PTIX)

Protagenic Therapeutics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:PTIX
DataHoraFonteTítuloCódigoCompanhia
14/08/202417:59Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PTIXProtagenic Therapeutics Inc
26/07/202418:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PTIXProtagenic Therapeutics Inc
14/02/202416:29Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PTIXProtagenic Therapeutics Inc
02/11/202317:29Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:PTIXProtagenic Therapeutics Inc
13/10/202313:48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTIXProtagenic Therapeutics Inc
17/04/202315:44Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:PTIXProtagenic Therapeutics Inc
22/03/202314:29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PTIXProtagenic Therapeutics Inc
14/11/202216:20Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PTIXProtagenic Therapeutics Inc
12/10/202207:01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:PTIXProtagenic Therapeutics Inc
08/03/202218:03Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:PTIXProtagenic Therapeutics Inc
15/02/202208:17Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PTIXProtagenic Therapeutics Inc
04/02/202218:33Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PTIXProtagenic Therapeutics Inc
23/11/202110:45TipRanksProtagenic Therapeutics (PTIX) Initiated with a Buy at Maxim GroupNASDAQ:PTIXProtagenic Therapeutics Inc
16/11/202111:58GlobeNewswire Inc.Protagenic Therapeutics Announces Third Quarter 2021 Results and Business UpdateNASDAQ:PTIXProtagenic Therapeutics Inc
10/09/202117:57Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:PTIXProtagenic Therapeutics Inc
30/08/202110:15GlobeNewswire Inc.Protagenic Therapeutics to Host Virtual Science Review Wednesday, September 8th at 10 AM ETNASDAQ:PTIXProtagenic Therapeutics Inc
17/08/202108:45GlobeNewswire Inc.Protagenic Therapeutics Announces Second Quarter 2021 Results and Provides Business UpdateNASDAQ:PTIXProtagenic Therapeutics Inc
13/08/202118:29Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:PTIXProtagenic Therapeutics Inc
23/07/202117:21GlobeNewswire Inc.Protagenic Therapeutics Updates Timeline for Commencement of Patient Enrollment for PT00114 Clinical TrialNASDAQ:PTIXProtagenic Therapeutics Inc
06/07/202107:17GlobeNewswire Inc.Protagenic Therapeutics to Host Webinar with Dr. Maurizio Fava for its Lead Molecule PT00114 on Tuesday, July 13th at 10:00 A...NASDAQ:PTIXProtagenic Therapeutics Inc
02/07/202117:48Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:PTIXProtagenic Therapeutics Inc
16/06/202110:15GlobeNewswire Inc.Protagenic Therapeutics to Present at the H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference on June 17...NASDAQ:PTIXProtagenic Therapeutics Inc
03/06/202119:13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTIXProtagenic Therapeutics Inc
29/04/202116:06GlobeNewswire Inc.Protagenic Therapeutics, Inc. Announces Closing of $13.2 Million Public Offering and Uplisting to NasdaqNASDAQ:PTIXProtagenic Therapeutics Inc
28/04/202118:30Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:PTIXProtagenic Therapeutics Inc
26/04/202121:58GlobeNewswire Inc.Protagenic Therapeutics, Inc. Announces Nasdaq Uplisting and Pricing of $13.2 Million Public OfferingNASDAQ:PTIXProtagenic Therapeutics Inc
13/02/201009:00PR Newswire (US)Performance Technologies Announces Rebranding of Company to PTNASDAQ:PTIX
12/02/201012:00PR Newswire (US)Performance Technologies Debuts NGN Xpress(TM) Product LineNASDAQ:PTIX
11/02/201011:00PR Newswire (US)Comfone Expands International Connectivity with Performance Technologies' SEGway(TM) Signalling SolutionNASDAQ:PTIX
27/01/201013:48PR Newswire (US)Performance Technologies Schedules Fourth Quarter 2009 Year End Earnings Release and Conference CallNASDAQ:PTIX
 Apresentando as notícias mais relevantes sobre:NASDAQ:PTIX

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
RCSL4
RECRUSUL PN
BOV
PRIO3
PETRORIO ON
BOV
AZEV4
AZEVEDO PN
BOV
FICT3
Fictor Alimentos ON
BOV
BRAV3
Brava Energia ON
BOV
GFSA3
GAFISA ON
BOV
IFCM3
Infracommerce Caxaas ON
BOV
FNAM11
Fundo Invest Amazonia Fi...
BOV
GOLL4
GOL PN
BOV
AMOB3
Automob Participacoes ON
BOV
RAIZ4
Raizen S.A PN
BOV
HOOT4
HOTEIS OTHON PN
BOV
ALPK3
Allpark Empreendimentos ... ON
BOV
RCSL3
RECRUSUL ON
BOV
FHER3
FER HERINGER ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados